Kyle Carver

About Kyle Carver

Kyle Carver is a chief financial officer at Evommune.

Kyle Carver reports to the SEC as an officer of 2 public companies, including Kadmon (KDMN).

Kyle Carver first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Kyle Carver in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Kyle Carver works with at each company, as listed on that company's latest Form D.

Sources

1. SECEvommune, Inc. Form D, filed Jan 8, 2025
2. SECForms 3, 4 and 5 filed by Kyle Carver (SEC filer 1757072)